Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Transdermal therapeutic system for the administration of rivastigmine
No-Receipt date
2013-01757 - 12/06/2013
No-Filing date
20130401148 - 12/06/2013
No-Granting date
3080936 - 17/06/2013
No-EPO application date
10179085.5 - 10/10/2006
No-EPO granting date
2292219 - 12/06/2013
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2013 - 11/07/2013
Expiration date
11/10/2026
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
US741511 P01/12/2005/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/27
A61K 9/70
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
486583
NOVARTIS AG
LICHTSTRASSE 35
4056 BASEL
SWITZERLAND
486585
LTS LOHMANN THERAPIE-SYSTEME AG
LOHMANNSTRASSE 2
56626 ANDERNACH
GERMANY
Inventors
Code
Firstname
Surname
1163272
GARGIULO, PAUL M.
1163273
LANE, ROGER MICHAEL
1163274
PLATT, BEATRIX
1163275
THEOBALD, FRANK
1163276
WALL, BETTINA
Representatives
Code
Firstname
Surname
Address
Town
Zip
742
KONSTANTINOS
KILIMIRIS
XATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
2119
KONSTANTINOS
KILIMIRIS
CHATZIGIANNI MEXI 7
ATHINA (ATTIKIS)
11528
GREECE
Owners History
Title Instruments
Date
Operation
Descreption
9/27/2013 12:00:00 AM
Διάφορες Μεταβολές (70004)
ΑΡ. ΠΡΩΤ. 4842/1-8-2013, ΚΩΔ. ΠΛΗΡ. 3190, (ΠΑΡΑΧΩΡΗΣΗ ΑΠΟΚΛΕΙΣΤΙΚΗ ΑΔΕΙΑΣ ΕΚΜΕΤΑΛΕΥΣΗΣ ).
9/27/2013 12:00:00 AM
Διάφορες Μεταβολές (70004)
ΟΙ ΔΙΚΑΙΟΥΧΟΙ ΤΗΣ ΑΙΤΗΣΗΣ ΠΑΡΑΧΩΡΗΣΑΣΝ ΑΠΟΚΛΕΙΣΤΙΚΗ ΑΔΕΙΑ ΕΚΜΕΤΑΛΕΥΣΗΣ ΣΤΗΝ ΕΤΑΙΡΕΙΑ " NOVARTIS (HELLAS) AEBE" ΠΟΥ ΕΔΡΕΥΕΙ ΣΤΟ 12ο Χλμ. Εθνικής Οδού 1, 14451 ΜΕΤΑΜΟΡΦΩΣΗ , ΕΛΛΑΔΑ.
Payments history
12 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).